Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

A new study uses shopping receipts to show how appetite changes from Ozempic and Wegovy affect grocery and restaurant ...

As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices in ways that extend far beyond individual health. When people in the United States begin using ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

On December 22, 2025, the U.S. Food and Drug Administration (FDA) formally approved Wegovy® pills, marking a major milestone ...

Three inmates, all accused of violent crimes, are back in custody after escaping from an Atlanta-area jail. It’s still unclear exactly how they got out, but police say their recorded jailhouse phone ...

Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity ...

A pill version of weight-loss drug Wegovy will be manufactured in the Triangle and could be available within weeks after the ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...